
MMC
USDMarsh & McLennan Companies Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$216.880
High
$219.720
Low
$212.200
Volume
0.36M
Company Fundamentals
Market Cap
108.0B
Industry
Insurance Brokers
Country
United States
Trading Stats
Avg Volume
2.31M
Exchange
NYQ
Currency
USD
52-Week Range
AI Analysis Report
Last updated: Apr 27, 2025MMC: Marsh & McLennan Companies Inc. Common Stock - Analyzing Recent Moves & What Might Come Next
Stock Symbol: MMC Generate Date: 2025-04-27 12:05:02
Alright, let's break down what's been going on with Marsh & McLennan, the big insurance and consulting firm, and see what the tea leaves (and the AI) might be suggesting.
What's Been Happening? The Recent Picture
First off, the news flow around MMC has been a bit of a mixed bag lately. We've seen several analysts tweaking their views. A few folks at Barclays, Jefferies, Wells Fargo, and UBS actually nudged their price targets higher in early April. That's usually a sign they see some potential upside or are feeling a bit more optimistic about the company's value. UBS even kept a "Buy" rating on the stock.
But hold on, it's not all sunshine. Keefe, Bruyette & Woods (KBW) has maintained an "Underperform" rating, which is less enthusiastic. More recently, KBW even slightly lowered their price target from $220 to $215 just a few days ago. Plus, news about a competitor, Aon, missing their profit targets due to higher costs could cast a bit of a shadow over the whole insurance brokerage sector, including MMC.
So, the analyst community isn't totally in agreement, showing a mix of cautious optimism (higher targets from some) and outright skepticism (the Underperform rating).
Now, let's look at the stock price itself. If you glance at the chart over the last month or so, you'll notice something pretty dramatic happened in early April. After climbing nicely into the $240s, the stock took a significant tumble, dropping sharply over a few days. It's been bouncing around and consolidating in the $210-$220 range since that drop. The last recorded price was around $219.
Putting the news and price together, we see a stock that recently fell hard despite some analysts raising targets earlier in the month. The most recent analyst action (KBW lowering their target) aligns more with the negative price move, while the Aon news adds a sector-wide concern.
What the AI Sees
Here's where things get interesting. An AI model looking at MMC is painting a different picture for the immediate future. It predicts the stock price will stay roughly flat today (0.00% change), but then sees potential upward movement: a 2.71% increase the next day and a 3.79% increase the day after that. The AI model actually has pretty high confidence in its prediction and gives MMC a decent overall recommendation score, highlighting "significant upside potential" and "market optimism." It even points to some technical signals suggesting a bullish trend and strong buying pressure recently, although it also notes a bearish MACD crossover and high debt levels fundamentally.
Putting It Together: What This Might Mean
Okay, so we have conflicting signals. Recent price action was negative (a sharp drop), analyst views are mixed (some raising targets, one lowering and maintaining a negative rating), a competitor had issues, but the AI is forecasting a near-term upward bounce from the current level.
Based on the AI's forecast and its stated confidence, the situation could be interpreted as the stock potentially being at a turning point after its recent fall. The AI seems to think the selling pressure might be easing and sees room for a move higher in the next couple of days.
If you were considering this stock and giving weight to the AI's outlook, the current price area, roughly around $219-$220, might be seen as a potential spot to consider getting in, aligning with the AI's prediction of upward movement starting soon and the entry points suggested by the AI recommendation data.
For managing risk, the AI data suggests a potential stop-loss level around $197.31. This is just above the stock's 52-week low, which makes sense as a point where you might decide the recent downturn is more serious. On the flip side, if the stock does move up as the AI predicts, a potential take-profit level suggested is around $230.77. This level is below the recent peak but above the current consolidation range, representing a reasonable target based on the AI's short-term outlook.
Quick Company Note
Remember, Marsh & McLennan is a giant in the insurance brokerage and consulting world. They make their money by helping companies manage risks and advising them on strategy and people issues. So, broader economic conditions and trends in the insurance market are always key things to watch for this company.
Disclaimer: This analysis is based on the provided data and AI model predictions as of the generate date. It is for informational purposes only and should not be considered financial advice. Stock markets are volatile, and prices can go down as well as up. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.
Related News
Insurance broker Aon misses quarterly profit estimates on higher cost
Insurance brokerage firm Aon missed Wall Street estimates for first-quarter profit on Friday, hurt by higher expenses.
Keefe, Bruyette & Woods Maintains Underperform on Marsh & McLennan Cos, Lowers Price Target to $215
Keefe, Bruyette & Woods analyst Meyer Shields maintains Marsh & McLennan Cos with a Underperform and lowers the price target from $220 to $215.
Barclays Maintains Equal-Weight on Marsh & McLennan Cos, Raises Price Target to $249
Barclays analyst Alex Scott maintains Marsh & McLennan Cos with a Equal-Weight and raises the price target from $246 to $249.
Jefferies Maintains Hold on Marsh & McLennan Cos, Raises Price Target to $244
Jefferies analyst Yaron Kinar maintains Marsh & McLennan Cos with a Hold and raises the price target from $237 to $244.
Wells Fargo Maintains Equal-Weight on Marsh & McLennan Cos, Raises Price Target to $232
Wells Fargo analyst Elyse Greenspan maintains Marsh & McLennan Cos with a Equal-Weight and raises the price target from $223 to $232.
UBS Maintains Buy on Marsh & McLennan Cos, Raises Price Target to $261
UBS analyst Brian Meredith maintains Marsh & McLennan Cos with a Buy and raises the price target from $259 to $261.
Keefe, Bruyette & Woods Maintains Underperform on Marsh & McLennan Cos, Raises Price Target to $220
Keefe, Bruyette & Woods analyst Meyer Shields maintains Marsh & McLennan Cos with a Underperform and raises the price target from $210 to $220.
AI PredictionBeta
AI Recommendation
Updated at: Apr 27, 2025, 06:33 PM
68.5% Confidence
Risk & Trading
Entry Point
$219.41
Take Profit
$230.77
Stop Loss
$197.31
Key Factors
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.